Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 6, 2010, Pages 983-987

  Itoh, Ayano ^a   Isoda, Katsuhiro ^a   Kondoh, Masuo ^a   Kawase, Masaya ^a   Watari, Akihiro ^a   Kobayashi, Masakazu ^b   Tamesada, Makoto ^b   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Kobayashi Pharmaceutical Co   (Japan)

Author keywords

Hepatoprotection; Lentinula edodes; Polyphenol; Syringic acid; Vanillic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN FIBRIL; HYDROXYPROLINE; SYRINGIC ACID; VANILLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL VIABILITY; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DRUG EFFECT; FIBROGENESIS; HEPATITIS; HISTOPATHOLOGY; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; SATELLITE CELL; TREATMENT RESPONSE;

ANIMALS; BIOLOGICAL PRODUCTS; CARBON TETRACHLORIDE POISONING; COLLAGEN; DRUG-INDUCED LIVER INJURY, CHRONIC; GALLIC ACID; HEPATIC STELLATE CELLS; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MICE; MICE, INBRED BALB C; MYCELIUM; RATS; RATS, SPRAGUE-DAWLEY; SHIITAKE MUSHROOMS; TRANSAMINASES; VANILLIC ACID;

EID: 77953380808     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.983     Document Type: Article

References (22)

1. Wasser S. P., Weis A. L., Crit. Rev. Immunol., 19, 65-96 (1999).
2. Suzuki H., Okubo A., Yamazaki S., Suzuki K., Mitsuya H., Toda S., Biochem. Biophys. Res. Commun., 160, 367-373 (1989).
3. Yamamoto Y., Shirono H., Kono K., Ohashi Y., Biosci. Biotechnol. Biochem., 61, 1909-1912 (1997).
4. Yamada T., Oinuma T., Niihashi M., Mitsumata M., Fujioka T.,Hasegawa K., Nagaoka H., Itakura H., J. Atheroscler. Thromb., 9,149-156 (2002).
5. Aggarwal B. B., Kumar A., Bharti A. C., Anticancer Res., 23, 363-398 (2003).
6. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., Hofman A., Rosenblat M., Volkova N., Presser D., Attias J., Hayek T., Fuhrman B., Drugs Exp. Clin. Res., 28, 49-62 (2002).
7. Levites Y., Weinreb O., Maor G., Youdim M. B., Mandel S., J. Neu-rochem., 78, 1073-1082 (2001).
8. Itoh A., Isoda K., Kondoh M., Kawase M., Kobayashi M., Tamesada M., Yagi K., Biol. Pharm. Bull., 32, 1215-1219 (2009).
9. Forrester I. T., Grabski A. C., Mishra C., Kelley B. D., Strickland W.N., Leatham G. F., Burgess R. R., Appl. Microbiol. Biotechnol., 33, 359-365 (1990).
10. Kivirikko K. I., Laitinen O., Prockop D. J., Anal. Biochem., 19, 249-255 (1967).
11. Kawada N., Tran-Thi T. A., Klein H., Decker K., Eur. J. Biochem.,213, 815-823 (1993).
12. Seglen P. O., Methods Cell Biol., 13, 29-83 (1976).
13. Gao X., Xu Y. X., Janakiraman N., Chapman R. A., Gautam S. C., Biochem. Pharmacol., 62, 1299-1308 (2001).
14. Aggarwal S., Ichikawa H., Takada Y., Sandur S. K., Shishodia S., Ag-garwal B. B., Mol. Pharmacol., 69, 195-206 (2006).
15. Aziz N. H., Farag S. E., Mousa L. A., Abo Zaid M. A., Microbios, 93, 43-54 (1998).
16. Guimaraes C. M., Giao M. S., Martinez S. S., Pintado A. I., Pintado M. E., Bento L. S., Malcata F. X., J. Food Sci., 72, C039-C043 (2007).
17. Kampa M., Alexaki V I., Notas G., Nifli A. P., Nistikaki A., Hatzoglou A., Bakogeorgou E., Kouimtzoglou E., Blekas G., Boskou D., Grava-nis A., Castanas E., Breast Cancer Res., 6, R63-R74 (2004).
18. Chen C. Y., Milbury P. E., Kwak H. K., Collins F. W., Samuel P., Blumberg J. B., J. Nutr., 134, 1459-1466 (2004).
19. Castillo T., Koop D. R., Kamimura S., Triadafilopoulos G., Tsukamoto H., Hepatology, 16, 992-996 (1992).
20. Albanis E., Friedman S. L., Clin. Liver Dis., 10, 821-833 (2006).
21. Friedman S. L., Toxicology, 254, 120-129 (2008).
22. Sato M., Suzuki S., Senoo H., Cell Struct. Funct., 28, 105-112 (2003).